• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

CRISPR-Cas9

Network of blood vessels against a white background
Research

Custom gene editor fixes mutation causing deadly disease in mice

Swapping out a mutant letter in the ACTA2 gene saved the lives of mice with an ultrarare vascular disease, while all untreated mice died.
Darren Incorvaia Sep 11, 2025 1:48pm
CRISPR Therapeutics

Appeals court reignites row over CRISPR discovery

May 13, 2025 8:00am
three spotlights on a stage

It's curtain close for Spotlight: Gene editing biotech shutters

Feb 19, 2025 4:28pm
gene edits scientists gene editing CRISPR

Editas cashes in on Vertex Cas9 licensing agreement for $57M

Oct 4, 2024 5:06am
gene editing edit gene CRISPR

CRISPR gene therapy for deafness works in young adult mice

Jul 11, 2024 9:15am
start race starting block runners go advance

Intellia showcases durability of one-and-done HAE option

Jun 2, 2024 8:00am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings